Tech Company Financing Transactions
RxAnte Funding Round
RxAnte closed a $25 million investment round on 12/21/2022. Backers included Trinity Capital Investment.
Transaction Overview
Company Name
Announced On
12/21/2022
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Undisclosed
Investors
Trinity Capital Investment (Lead Investor)
Proceeds Purpose
The company intends to use the funds to expand its business reach, continuing its work with health plans to bring down the $528 billion annual cost of under-use, over-use, and misuse of prescription drugs.
Company Information
Company Status
Private & Independent
Industry
Software
Mailing Address
2233 Wisconsin Ave. NW 502
Washington, DC 20007
USA
Washington, DC 20007
USA
Phone
Website
Email Address
Overview
Four out of five physician visits end with a prescription being written. Yet for many patients with chronic conditions, complications arise, health deteriorates, and costs spiral -- all because potentially effective medications are not taken as prescribed.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Joshua Benner
Chief Operating Officer
Peter Aldrich
Vice President
Loren Lidsky
Vice President
Adam Steinberg
VP - Bus. Development
Steve Nickerson
VP - Client Services
Kerri Petrin
VP - Finance
Corbin Director
VP - General Counsel
Eileen Casal
VP - Product Management
Amie Joyce
Browse more venture capital transactions:
Prev: 12/21/2022: Gynger venture capital transaction
Next: 12/21/2022: Fiscozen venture capital transaction
Share this article
News on VC Transactions
We do our best to record tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs